Part 2 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022
Ireland Urged to Champion A European Neurological Health Strategy During its EU Presidency
July 22, 2026
A coalition of Irish and European organisations representing people affected by neurological conditions, researchers and clinicians, has called on Ireland to use its Presidency of the Council of the European Union to champion the development of a European Neurological Health Strategy.
Latest Posts
-
-
Breaking newsCOVID-19
COVID-19 Breaking News: Cross-Sectional Case Control Studies (Part 1)
January 10, 2022Part 1 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022 -
Our highlighted selection of Covid-related case series and case reports from the scientific press for January 2022
-
Our highlighted selection of Covid-related expert opinions from the scientific press for January 2022
-
Our highlighted selection of miscellaneous Covid-related studies from the scientific press for January 2022
-
Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2022.
-
The EAN Education Committee is happy to announce the selection of candidates for the Clinical Fellowship Programme 2022.
-
With so few chances for EAN staff and members to meet in person, we decided to introduce the team behind the scenes. This time it's Lucia, Head of the Memberhip and Scientific Departments, and Anja, from the Communications Department.
-
Executive PageEAN Congress newsFeatured Slider
Executive Page: Submit, register and join us in Vienna for EAN 2022!
January 3, 2022EAN Programme Committee Chair, Tony Marson, on abstract submission, registration and the preliminary programme for EAN 2022. -
Paper of the MonthFeatured Slider
Research Paper of the Month: The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
January 3, 2022Our research paper of the month is a multicentre, randomised and double-blind phase 2 study with a futility design, exploring the efficacy and the safety of guanabenz in patients with probable or definite amyotrophic lateral sclerosis (ALS). -
Paper of the MonthCOVID-19Featured Slider
Covid-19 Paper of the month: Prospective postmortem evaluation of 735 consecutive SARS CoV 2 associated death cases
January 3, 2022Our authors of the month conducted a systematic review of SARS-CoV-2-associated deaths in Hamburg, Germany, from March to December 2020, using conventional autopsy, ultrasound-guided minimally invasive autopsy, postmortem computed tomography (PMCT) and medical record review. -
EBC
Best practices for patient safety: An EU-wide view on the use of medicines off-label
December 31, 2021On 30 November the European Brain Council held an event to build on the latest discussions on the Declaration on Good Off-Label Use Practices. -
EAN NewsEFNA
OneNeurology European Summit underlines urgent need to prioritise neurology and drive change
December 31, 2021The OneNeurology European Summit took place on 17 December 2021 under the patronage of the Slovenian Presidency in the Council of the EU -
Read the latest reports on EAN clinical fellowships in Lille (FR) and Münster (DE)
-
Read the latest reports on EAN clinical fellowships in Paris (FR) and Erlangen (DE)









